In this section, we will explore 4 case studies from patients with varying interstitial lung disease, including IPF, rheumatoid arthritis, scleroderma, and hypersensitivity pneumonitis.
You are now leaving a Boehringer Ingelheim Pharmaceuticals, Inc. site. Boehringer Ingelheim Pharmaceuticals, Inc. has not reviewed the contents of all pages and sites that may be linked to this site. Boehringer Ingelheim
Pharmaceuticals, Inc. is not responsible and disclaims any liability for the content of any other page or site or for any viruses or similar harmful programs that may be present on such pages or sites. Linking to any other
page or site is at your own risk.